Medtronic Plc - Enterprise Tech Ecosystem Series
|Medtronic Plc - Enterprise Tech Ecosystem Series|
Published: June 24, 2022
Content info: 21 Pages
Delivery time: 1-2 business days
Medtronic Plc (Medtronic), founded in 1949, is a medical technology, solutions, and services company which designs, develops, manufactures, and markets a wide range of medical devices and solutions for the treatment of heart failure; heart valve disorders; diseases of the coronary artery; aortic; peripheral vascular; venous, renal, and neurological diseases; spine and musculoskeletal disorders; and diseases of the ear, nose, and throat. It also provides biologic solutions for the orthopedic and dental markets. In the US, the company sells its products through a direct salesforce, and in other countries, through direct sales representatives and independent distributors. It serves hospitals, third-party healthcare providers, clinics, and institutions including governmental health care programs, distributors, and group purchasing organizations in Asia-Pacific, Europe, the Americas, the Middle East, and Africa.
Medtronic MedTech Innovation Accelerator is a new accelerator and incubator program in Minhang District, Shanghai, China to provide support to medical technology startups in the country and worldwide and will help fulfill unmet medical and clinical needs in China.
Medtronic announced opening of two RandD centers in Israel (Yokneam and Jerusalem) in collaboration with Israel Innovation Authority, which will provide a $14 million grant distributed over three years to the company. As per the agreement, Medtronic would employ 100 employees in these RandD centers.
This report provides insight into Medtronic's fintech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its estimated ICT budget, and its major ICT contracts.